Mathes Company »

Alnylam Pharmaceuticals shares owned by Mathes Company

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Mathes Company from 13F filings

Historical chart of Mathes Company investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Mathes Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Mathes Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $527k 1.2k 456.28
2025-06-30 $377k 1.2k 326.41